CAS: 1032754-93-0 - (S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one
Formula:C23H30N8O3S
InChI:InChI=1S/C23H30N8O3S/c1-14-17(13-29-3-5-31(6-4-29)22(33)15(2)32)35-19-18(14)27-20(16-11-25-23(24)26-12-16)28-21(19)30-7-9-34-10-8-30/h11-12,15,32H,3-10,13H2,1-2H3,(H2,24,25,26)/t15-/m0/s1
- Synonyms:
- Gdc-0980
- Gne 390
- (S)-1-(4-((2-(2-aMinopyriMidin-5-yl)-7-Methyl-4-Morpholinothieno[3,2-d]pyriMidin-6-yl)Methyl)piperazin-1-yl)-2-hydroxypropan-1-one
- Gdc-0980 (Rg7422)
- Apitolisib
- (2S)-1-(4-{[2-(2-Amino-5-pyrimidinyl)-7-methyl-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl}-1-piperazinyl)-2-hydroxy-1-propanone
Apitolisib
CAS:1032754-93-0
Formula:
C23H30N8O3S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
498.6011
Ref: IN-DA0035ZH
5mg | 192.00 € | ||
10mg | 192.00 € | ||
25mg | 266.00 € | ||
50mg | 495.00 € | ||
100mg | 524.00 € |
Estimated delivery in United States, on Thursday 12 Dec 2024
Apitolisib
CAS:1032754-93-0
Apitolisib (RG 7422) is a PI3K inhibitor, used in cancer trials, targeting PI3Kα, β, δ, …
Formula:
C23H30N8O3S
Purity:
98.28% - 99.52%
Color and Shape:
Solid
Molecular weight:
498.6
Ref: TM-T1916
2mg | 45.00 € | ||
5mg | 63.00 € | ||
10mg | 96.00 € | ||
25mg | 155.00 € | ||
50mg | 242.00 € | ||
100mg | 397.00 € |
Estimated delivery in United States, on Thursday 19 Dec 2024
Ref: 7W-GW1302
1mg | 265.00 € | ||
5mg | 383.00 € | ||
10mg | 619.00 € |
Estimated delivery in United States, on Thursday 19 Dec 2024
GDC-0980
Controlled ProductCAS:1032754-93-0
Applications GDC-0980 is used in the synthesis of PI3K inhibitors to treat carcinomas. Potent PI3K/mTOR …
Formula:
C23H30N8O3S
Color and Shape:
Neat
Molecular weight:
498.6
Ref: TR-G303000
5mg | 212.00 € | ||
50mg | 771.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
(S)-1-(4-((2-(2-Aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one
CAS:1032754-93-0
(S)-1-(4-((2-(2-Aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one is a CDK4/6 inhibitor that blocks the activity of these enzymes and inhibits cell …
Formula:
C23H30O3N8S
Purity:
Min. 95%
Molecular weight:
498.6 g/mol
Ref: 3D-FA34129
1mg | To inquire | ||
2mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire |
Estimated delivery in United States, on Thursday 23 Jan 2025